Interferon-γ Acts Directly on Rejecting Renal Allografts to Prevent Graft Necrosis
Open accessAbstract
In transplant rejection interferon (IFN)-gamma regulates the recipient immune response but also acts directly on IFN-gamma receptors in the graft. We investigated these direct actions by comparing rejecting kidneys from donors lacking IFN-gamma receptors (GRKO mice) or control donors (129Sv/J) in CBA recipients. Beginning day 5, 129Sv/J kidneys displayed high major histocompatibility complex (MHC) expression, progressive infiltration by inflammatory cells, but no thrombosis and little necrosis, even at day 21. GRKO kidneys showed increasing fibrin thrombi in small veins, peritubular capillary congestion, hyaline casts, and patchy parenchymal necrosis, progressing to near total necrosis at day 10. Terminal dUTP nick-end labeling assays were positive only in the interstitial infiltrate, confirming that massive cell death in GRKO transplants was not apoptotic. Paradoxically, GRKO kidneys showed little donor MHC induction and less inflammatory infiltration. Both GRKO and 129Sv/J allografts evoked vigorous host immune responses including alloantibody and mRNA for cytotoxic T cell genes (perforin, granzyme B, Fas ligand), and displayed similar expression of complement inhibitors (CD46, CD55, CD59). GRKO kidneys displayed less mRNA for inducible nitric oxide synthase and monokine inducible by IFN-gamma but increased heme oxygenase-1 mRNA. Thus IFN-gamma acting on IFN-gamma receptors in allografts promotes infiltration and MHC induction but prevents early thrombosis, congestion, and necrosis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IFN-γ has been shown to promote allograft tolerance in certain settings by counteracting the effects of IL-5 and IL-6.
“IFN-γ has been shown to promote allograft tolerance in certain settings by counteracting the effects of both IL-5 and IL-6, which are strong mediators of allograft rejection, as previously published and also observed in our case26,32–36.”
From Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 65 · Cited by 78
Research works printed but not linked: 4
- Goes N, Urmson J, Hobart M, Halloran PF: The unique role of inter- feron-␥ in the regulation of MHC expression on arterial endothelium. Transplantation 1996, 62:1889 -1894
- Goes N, Sims T, Urmson J, Vincent D, Ramassar V, Halloran PF: Disturbed MHC regulation in the interferon-␥ knockout mouse. J Im- munol 1995, 155:4559 -4566
- Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Bat- teux F, Muller S, Huang S, Boissier M-C, Fournier C: High suscepti- bility to collagen-induced arthritis in mice lacking IFN. J Immunol 1997, 158:5501-5506
- Vermeire K, Heremans M, Vandeputte M, Huang S, Billiau A, Matthys P: Accelerated collagen-induced arthritis in IFN. J Immunol 1997, 158:5507-5513
- Authors
- Halloran, P. F., Afrouzian, M., Ramassar, V., Urmson, J., Zhu, L.-F., Helms, L. M. H., Solez, K., & Kneteman, N. M.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Halloran, Philip F.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 158
- Issue
- 1
- Pages
- 215-226
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1850268
- OpenAlex
- W1973994927
- Cited by
- 78
- References
- 65
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 3 · 2013: 6 · 2012: 2
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universität Zürich
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- interferon-gamma, renal allograft rejection, graft necrosis, inflammatory cell infiltration, cytotoxic T lymphocytes, complement inhibitors, inducible nitric oxide synthase, heme oxygenase-1, apoptosis, graft vasculopathy
- MeSH terms
- Interferon gamma Receptor, Animals, Gene Expression Regulation, Graft Rejection, H-2 Antigens, Immunohistochemistry, Interferon-gamma, Isoantibodies, Leukocytes, Mononuclear, Mice, Inbred CBA, Mice, Inbred Strains, Necrosis, RNA, Messenger, Transplantation, Homologous, CD4 Antigens, Kidney Transplantation, CD8 Antigens, CD3 Complex, Receptors, Interferon, Leukocyte Common Antigens, Mice, Knockout, In Situ Nick-End Labeling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review